Medical Device Structural Adhesives Market Global Report 2026

The medical device structural adhesives market size has grown strongly in recent years. It will grow from $1.6 billion in 2025 to $1.75 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing adoption of minimally invasive medical devices, growing demand for durable medical device assembly, rising use of polymer and metal components in medical devices, increasing emphasis on device reliability and patient safety, and growing demand for permanent fluid-tight bonding.

The medical device structural adhesives market size is expected to see strong growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. Growth during the forecast period is anticipated to be driven by increasing demand for advanced biocompatible adhesive formulations, rising adoption of wearable and connected medical devices, growing development of implantable medical technologies, increasing demand for lightweight and miniaturized medical devices, and expanding use of automated adhesive dispensing and curing processes. Key trends during the forecast period include greater adoption of biocompatible structural adhesives, rising demand for sterilization-resistant adhesive formulations, increasing use of low-outgassing medical adhesives, growing demand for bonding dissimilar substrates, and increasing preference for fast-curing structural adhesives.

The increasing demand for medical devices is expected to propel the growth of the medical device structural adhesives market going forward. Medical devices are instruments, apparatuses, machines, or implants used by healthcare providers to diagnose, treat, monitor, or prevent diseases. The demand for medical devices is increasing due to the rising prevalence of chronic diseases, which require continuous diagnosis, monitoring, and treatment. Medical device structural adhesives enable reliable bonding between different materials, supporting the manufacture of durable, high-performance devices that comply with stringent quality and regulatory standards. For instance, in May 2026, according to the U.S. Food and Drug Administration (FDA), a US-based federal agency, the cumulative number of Breakthrough Devices receiving marketing authorization increased from 179 in 2025 to 198 in 2026, while cumulative Breakthrough Device designations increased from 1,179 to 1,284 over the same period. This growth reflects the accelerating development and commercialization of innovative medical technologies, increasing demand for high-performance structural adhesives used in the assembly of advanced medical devices. Therefore, the increasing demand for medical devices is driving the growth of the medical device structural adhesives market.

Major companies operating in the medical device structural adhesives market are concentrating on technological advancements in adhesive chemistry, such as light cure bonding technology, to improve manufacturing efficiency, enable rapid curing, enhance bond strength, and support the assembly of increasingly complex medical devices. Light cure bonding technology uses UV or visible light exposure to initiate rapid polymerization of adhesive formulations, allowing manufacturers to bond flexible substrates such as thermoplastic elastomers with high precision and minimal processing time. For instance, in January 2025, Henkel, a Germany-based industrial adhesives company, launched Loctite AA 3952 and Loctite SI 5057, two light cure adhesives developed for flexible medical device assembly. Both products are tested for ISO 10993 biocompatibility, formulated to effectively bond thermoplastic elastomer substrates, and engineered to maintain performance under heat and humidity aging conditions that are critical for device reliability.

In December 2024, H.B. Fuller Company, a US-based manufacturer of adhesives, sealants, and specialty chemical products, acquired Medifill Ltd. for approximately €49.9 million ($51.3 million). Through the acquisition, H.B. Fuller expanded its Medical Adhesive Technologies portfolio by strengthening its medical-grade cyanoacrylate adhesive capabilities and increasing its presence in the wound closure and tissue adhesives market. Medifill Ltd. is an Ireland-based manufacturer of medical-grade cyanoacrylate tissue adhesives and wound closure technologies.

Major companies operating in the medical device structural adhesives market are Henkel AG & Co. KGaA, 3M Company, Dow Inc., Sika AG, Arkema SA, DuPont de Nemours Inc., H.B. Fuller Company, Huntsman Corporation, Illinois Tool Works Inc., Avery Dennison Corporation, The Lubrizol Corporation, Ashland Inc., DELO Industrie Klebstoffe GmbH & Co. KGaA, Meridian Adhesives Group, Dymax Corporation, Parson Adhesives Inc., Chemence Medical Inc., Panacol-Elosol GmbH, Adhezion Biomedical LLC, Permabond LLC, Master Bond Inc., Scott Bader Company Ltd., Hubei Huitian New Materials Co. Ltd.

North America was the dominating region in the medical device structural adhesives market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the medical device structural adhesives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical device structural adhesives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.